Close
HO CHI MINH CITY RIVER FESTIVAL EXPANDS IN SCALE, IGNITING SUMMER TOURISM IN 2024 Jun 3, 2024 12:04AM

The 2nd Ho Chi Minh City River Festival 2024 will take place from May 31 to June 9, 2024, featuring a series of exciting sports, entertainment, and artistic activities.

HO CHI MINH CITY, Vietnam, June 3, 2024 /PRNewswire/ -- Ho Chi Minh City always knows how to captivate visitors with its unique charm, vibrant lifestyle, and impressive cultural and historical heritage. Adding to its allure, the city's annual festivals have carved out a distinctive identity, drawing an... (continue reading...)


Private equity finds a footing but still searching for momentum as two-year slump bottoms out--Bain & Company's PE Midyear Report Jun 3, 2024 12:01AM
  • Global PE looks to have arrested its freefall as the slide in dealmaking and exits levels off
  • Buyout deal numbers set to stay flat vs 2023 with higher average deal size driving a rise in deal value
  • Multiple challenges facing the sector put the premium for PE firms on adjusting to a new normal

BOSTON, June 3, 2024 /PRNewswire/ --The two-year long slump in global private equity looks finally to be bottoming out, with the industry finding a footing from which to climb... (continue reading...)


Sigma 28-45mm F1.8 Full Frame DG DN Art Lens Announced; YouTube Video First Look, Learn More Info at B&H Photo Video Jun 3, 2024 12:00AM

Photography News: Sigma has released a fast full-frame zoom offering a versatile focal length range, a bright f/1.8 design, and optical performance that rivals a prime.

NEW YORK, June 3, 2024 /PRNewswire/ -- B&H is pleased to share the new Sigma 28-45mm f/1.8 DG DN Art lens—a unique full-frame zoom that features a constant f/1.8 maximum aperture and a short wide-angle to normal-length zoom range. This lens is effectively the full-frame mirrorless successor to their... (continue reading...)


ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests Jun 3, 2024 12:00AM

SALT LAKE CITY, June 3, 2024 /PRNewswire/ -- ARUP Laboratories is backing a federal lawsuit filed by the American Clinical Laboratory Association (ACLA) challenging the FDA's final rule to regulate laboratory-developed tests (LDTs) as medical devices. The lawsuit states that the FDA does not have legal authority over medical testing services from Congress and asserts that regulating these services is unreasonable.

... (continue reading...)


10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours Jun 3, 2024 12:00AM

LITTLE ROCK, Ark., June 3, 2024 /PRNewswire/ -- 10 Fitness announces its commitment to uninterrupted access for members around the clock with its innovative SARA system, making sure the fitness journey never hits a pause.

While most non-staffed gyms leave members stranded outside if access issues arise during unstaffed hours, 10 Fitness stands apart. Thanks to SARA (Secured Access and Revenue Automation), members enjoy seamless entry to... (continue reading...)


More PRNewswire

View Older Stories

Jun 2, 2024 11:35PM MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
Jun 2, 2024 11:30PM The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
Jun 2, 2024 10:57PM Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
Jun 2, 2024 10:28PM NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
Jun 2, 2024 10:15PM 2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
Jun 2, 2024 10:00PM Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
Jun 2, 2024 10:00PM LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
Jun 2, 2024 09:41PM Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
Jun 2, 2024 09:30PM Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
Jun 2, 2024 09:19PM China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
Jun 2, 2024 09:14PM Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
Jun 2, 2024 09:00PM TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
Jun 2, 2024 09:00PM MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
Jun 2, 2024 06:15PM Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
Jun 2, 2024 06:01PM One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
Jun 2, 2024 04:00PM FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
Jun 2, 2024 03:45PM izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
Jun 2, 2024 12:40PM GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
Jun 2, 2024 12:30PM Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
Jun 2, 2024 11:32AM Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
Jun 2, 2024 11:24AM Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
Jun 2, 2024 11:00AM Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
Jun 2, 2024 10:45AM ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
Jun 2, 2024 10:25AM ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
Jun 2, 2024 10:00AM MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
Jun 2, 2024 10:00AM Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
Jun 2, 2024 09:43AM Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
Jun 2, 2024 09:30AM Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
Jun 2, 2024 08:42AM Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 2, 2024 08:30AM Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
Jun 2, 2024 08:30AM Vention to democratize industrial automation using NVIDIA AI technologies
Jun 2, 2024 08:00AM OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
Jun 2, 2024 07:00AM Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
Jun 2, 2024 06:18AM Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jun 2, 2024 01:13AM Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
Jun 1, 2024 11:56PM Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
Jun 1, 2024 08:25PM Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
Jun 1, 2024 08:17PM CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
Jun 1, 2024 08:00PM Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
Jun 1, 2024 08:00PM Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00PM Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
Jun 1, 2024 07:13PM GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
Jun 1, 2024 06:09PM LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Jun 1, 2024 05:52PM Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
Jun 1, 2024 04:30PM Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
Jun 1, 2024 03:40PM BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
Jun 1, 2024 03:00PM Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Jun 1, 2024 01:45PM Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
Jun 1, 2024 01:42PM Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
Jun 1, 2024 01:10PM Taseko Announces that Operations at its Gibraltar Mine have been Suspended
View Older Stories